Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: Relationship to transition zone volume

被引:68
作者
Stamey, TA [1 ]
Yemoto, CE [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA
关键词
prostate; prostate-specific antigen; biopsy; sensitivity and specificity; prostatic neoplasms;
D O I
10.1016/S0022-5347(05)67986-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We evaluated the relative usefulness of total, free and complexed serum prostate specific antigen (PSA), and their ratios for distinguishing positive from negative biopsy of prostates in a university referral practice. Materials and Methods: We compared 90 consecutive men who had 2 sets of 6 negative systematic biopsies with 70 who had at least 5 mm. Of prostate cancer in systematic biopsies during the same period at our institution. Total prostate and transition zone volumes were determined by transrectal ultrasound. The Bayer,dagger DPC double dagger and Hybritech closed integral assays were performed to measure total, free and complexed serum PSA. Receiver operating characteristics curves were constructed for all forms of serum PSA and their ratios as well as prostate size to distinguish true positive (sensitivity) from false-positive (1 minus specificity) fractions. Results: Complexed PSA was only marginally better than total serum PSA. Free-to-total, complexed-to-total and prostate size had highly significant areas under the curves of greater than 80%. Free PSA only was better than complexed or total PSA. When factored by prostate volume, total PSA performed as well as the PSA ratios, and transition zone volume was consistently better than total prostate volume. DPC free-to-total ratios were equivalent to Hybritech ratios in all respects. Conclusions: Complexed PSA is only marginally better than total PSA for distinguishing negative from positive biopsy of prostates. It is inferior to free PSA and far less useful than free-to-total or complexed-to-total ratios. Prostate size is a decisive variable in men in whom we avoided the expected 25% false-negative biopsy rate in terms of specificity and hopefully avoided insignificant cancer in terms of sensitivity. In the future the performance of PSA serum markers should be related to a transition zone volume of less than 20, 20 to 60 and greater than 60 gm. when comparing assays to each other.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 33 条
[11]   CORRELATION BETWEEN SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS AND THE VOLUME OF THE INDIVIDUAL GLANDULAR ZONES OF THE HUMAN PROSTATE [J].
HAMMERER, PG ;
MCNEAL, JE ;
STAMEY, TA .
JOURNAL OF UROLOGY, 1995, 153 (01) :111-114
[12]   SERUM PSA ADJUSTED FOR VOLUME OF TRANSITION ZONE (PSAT) IS MORE ACCURATE THAN PSA ADJUSTED FOR TOTAL GLAND VOLUME (PSAD) IN DETECTING ADENOCARCINOMA OF THE PROSTATE [J].
KALISH, J ;
COONER, WH ;
GRAHAM, SD .
UROLOGY, 1994, 43 (05) :601-606
[13]   SERIAL PROSTATIC BIOPSIES IN MEN WITH PERSISTENTLY ELEVATED SERUM PROSTATE-SPECIFIC ANTIGEN VALUES [J].
KEETCH, DW ;
CATALONA, WJ ;
SMITH, DS .
JOURNAL OF UROLOGY, 1994, 151 (06) :1571-1574
[14]   PROSTATIC TRANSITION ZONE BIOPSIES IN MEN WITH PREVIOUS NEGATIVE BIOPSIES AND PERSISTENTLY ELEVATED SERUM PROSTATE-SPECIFIC ANTIGEN VALUES [J].
KEETCH, DW ;
CATALONA, WJ .
JOURNAL OF UROLOGY, 1995, 154 (05) :1795-1797
[15]   Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer [J].
Levine, MA ;
Ittman, M ;
Melamed, J ;
Lepor, H .
JOURNAL OF UROLOGY, 1998, 159 (02) :471-475
[16]  
LILJA H, 1991, CLIN CHEM, V37, P1618
[17]   Transition zone prostate specific antigen density: Lack of use in prediction of prostatic carcinoma - Editorial comment - Reply [J].
Lin, DW ;
Gold, MH ;
Ransom, S ;
Ellis, WJ ;
Brawer, MK .
JOURNAL OF UROLOGY, 1998, 160 (01) :82-82
[18]   Prostate specific antigen adjusted for the transition zone volumes as an indicator of prostate cancer [J].
Maeda, H ;
Arai, Y ;
Ishitoya, S ;
Okubo, K ;
Aoki, Y ;
Okada, T .
JOURNAL OF UROLOGY, 1997, 158 (06) :2193-2196
[19]   BASIC PRINCIPLES OF ROC ANALYSIS [J].
METZ, CE .
SEMINARS IN NUCLEAR MEDICINE, 1978, 8 (04) :283-298
[20]  
Myrtle J, 1986, ADV CANC DIAGNOSIS